Browse Category

NASDAQ:ZION News 16 October 2025

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Fraudulent Loan Bombshell Hits Zions’ Books Zions Bancorporation shocked the market this week by revealing a significant credit mishap at its California division. In a late Wednesday 8-K filing, the Salt Lake City-based regional bank disclosed it discovered potential fraud in two related commercial loans totaling about $60 million Investing. After an internal review unearthed “misrepresentations and irregularities” by the borrowers, Zions decided to write off $50 million of the loans and take a provision for the rest, effectively recognizing a total $60 million exposure as likely lost Investing. The bank has already accelerated the loans to default and filed

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop